Back to discover
Disease

Viremia

Late-stage therapeutic developmentEmerging research
MeSHViremia
1
Publications
16
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Mayaro virus pathogenesis and immunity in rhesus macaques.

Research2023-11-20PLoS neglected tropical diseases

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 3 clinical trials expected to report results, the earliest in Q3 2027.
Upcoming Milestones
Clinical Milestones4View
Results expected 3
Recently completed 1
Activity timeline4

Clinical trials

15 sponsors · 1 new · 0 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
16
All trials
6
Active
6
Late-stage
6
Completed
Late-stage studies

An Adaptive Randomised Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney Pancreas Transplant Recipients

Phase 3 · Recruiting · The University of Queensland

VALganciclovir vs. LETermovir for Primary Prevention of CMV in Moderate to High-Risk Heart Transplant Recipients (The VALET-CMV Study)

Phase 2/3 · Recruiting · Columbia University

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Phase 4 · Recruiting · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlled

Phase 2/3 · Completed · Memo Therapeutics AG

Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

Phase 3 · Terminated · ANRS, Emerging Infectious Diseases

Effect of Fluoroquinolones on BK Viremia in the Renal Transplant Recipient, A Multi-Center Study

Phase 4 · Completed · Brigham and Women's Hospital
Recruiting

An Adaptive Randomised Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney Pancreas Transplant Recipients

Phase 3 · Recruiting · The University of Queensland

VALganciclovir vs. LETermovir for Primary Prevention of CMV in Moderate to High-Risk Heart Transplant Recipients (The VALET-CMV Study)

Phase 2/3 · Recruiting · Columbia University

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Phase 4 · Recruiting · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

A Prospective Exploratory Study of EBV-AST Cell Injection for the Treatment of EBV-Related Diseases After Allogeneic Hematopoietic Stem Cell Transplantation

Phase 1/2 · Recruiting · Daihong Liu

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study

Phase 2 · Recruiting · University Medical Centre Ljubljana
Recently completed

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlled

Phase 2/3 · Completed · Memo Therapeutics AG

A Phase II Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Phase 2 · Completed · Memorial Sloan Kettering Cancer Center

A Prospective Multicenter Open-label, Not Controlled Phase Ib-II Clinical Trial to Assess the Safety and Immunologic Efficacy of Virus-specific T Lymphocytes From the Best Donor in Receptors of Hematopoietic Progenitor Allogeneic Transplant

Phase 1/2 · Completed · Banc de Sang i Teixits

Double Blinded Placebo Controlled Study to Assess Clinical and Antiviral Activity of Valganciclovir (VAL) in Solid Organ Transplant Donors to Reduce Viral Transmission From Donor to Recipient

Phase 2 · Completed · University of Minnesota

Effect of Fluoroquinolones on BK Viremia in the Renal Transplant Recipient, A Multi-Center Study

Phase 4 · Completed · Brigham and Women's Hospital

Randomized Controlled Double-Blind Trial of the Comparative Viremia, Immunogenicity and Safety of a 17-D Live Attenuated Yellow Fever Vaccine (YF-VAX)Given Alone or in Combination With Human Immune Globulin (Gama STAN S/D)

Phase 1 · Completed · Emory University

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Mayaro virus pathogenesis and immunity in rhesus macaques.

PLoS neglected tropical diseases · 2023 · 14 cites
Recent publications

Mayaro virus pathogenesis and immunity in rhesus macaques.

PLoS neglected tropical diseases · 2023 · 14 cites
Major themes3
  • Alphavirus1
  • Alphavirus Infections1
  • Chikungunya virus1
Leading journals1
  • PLoS neglected tropical diseases1
Leading researchers8
  • Andoh TF1
  • Axthelm MK1
  • Barber-Axthelm AM1
  • Chun K1
  • DeFilippis V1
  • Denton M1
  • Fei SS1
  • Fisher MB1
Affiliations (unnormalised)3
  • Oregon Health and Science University1
  • Oregon National Primate Research Center1
  • Vaccine and Gene Therapy Institute1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

The presence of viruses in the blood.

Identifiers
MeSHViremia
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.